Investor Views: "Should I Cash in my £850,000 Pension?"

Private investor Andrew Knight fears falling foul of lifetime pension contribution limits if he accesses a scheme from a previous employer

Emma Simon 15 September, 2017 | 1:02PM
Facebook Twitter LinkedIn

Golden eggs

Pension freedom rules have created new investment opportunities for people like Andrew Knight. Knight currently runs his own marketing business after taking redundancy a year ago. He now faces a decision about what to do with a former final salary pension.

He says: “I worked for a bank for around 20 years earlier on in my career, and during this time contributed to their final salary scheme. This pension is on track to start paying me an income at the age of 65.”

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
AXA Framlington Biotech GBP Z Acc486.70 GBP-0.18Rating
AXA Framlington UK Select Opps R Acc4,116.01 GBP-0.12Rating
Liontrust Russia A Acc GBP6.23 GBP1.04Rating

About Author

Emma Simon

Emma Simon  is a financial journalist, specialising in investment and consumer issues, writing for Morningstar.co.uk